W. Eberhardt (Essen, Germany), G. Scagliotti (Orbassano, Italy)
Selective pulmonary artery perfusion followed by blood flow occlusion: new challenge for the treatment of lung cancer
M. J. Grootenboers, B. P. Van Putte, W. J. Van Boven, J. M. Hendriks, P. E. Van Schil, G. Pasterkamp, G. Folkerts, F. M. Schramel (Breda, Nieuwegein, Utrecht, Netherlands; Edegem, Belgium)
|   |
External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non small cell lung cancer
S. Vucicevic, B. Lukac, J. Stankovic, N. Jovanovic-Korda, E. Sudjic-Bukurov (Belgrade, Serbia And Montenegro)
| |
Pulmonary resection for renal cell carcinoma metastases: a retrospective analysis of 21 patients
A. Reshetov, P. Yablonsky, A. Pichurov, F. Markin (Saint Peterbuge, Russian Federation)
| |
The expression of Bcl-xl correlates with improved survival in chemo-naive, surgically resected NSCLC patients
L. H. Schmidt, A. Kuemmel, S. Biesterfeld, M. Sebastian, C. Taube, M. Schuler, R. Buhl, R. Wiewrodt (Mainz, Germany)
| |
Overexpression of activated Akt does not correlate with radiologic chemoresponse
S. Z. Ahmed, T. J. Sheppard, P. S. Talwar, M. L. Hearp, M. Grant, O. David (Chicago, IL, Pittsburgh, PA, United States Of America)
| |
Disease relapse after radical surgery of NSCLC
G. Radosavljevic Asic, D. Subotic, V. Kacar Kukric, T. Adzic (Belgrade, Serbia And Montenegro)
| |
Treatment for non small cell lung cancer presenting with synchronous solitary brain metastases
N. Jovanovic Korda, G. Gligorijevic, D. Grujicic, S. Vucicevic (Belgrade, Serbia And Montenegro)
| |
Lung cancer treatment strategies in district general hospital
M. J. Malik, M. Finlay (Rochdale, United Kingdom)
| |
Combination of argon plasma coagulation and photodynamic therapy in thoracoscopic pleurodesis
V. Klimenko, O. Chaika, A. Arseniev, M. Gelfond, A. Barchuk, A. Barchuk (Saint-Petersburg, Russian Federation)
| |
A phase I study of aerosolized gemcitabine in non-small-cell lung cancer
F. Gagnadoux, L. Vecellio, C. Prunier, J. Hureaux, C. Majoral, P. Diot, M. Boisdron, J. L. Beaulieu, C. Valat, J. M. Halimi, B. Giraudeau, D. Grimbert, A. Le Pape, J. L. Racineux, T. Urban, E. Lemarié (Angers, Tours, Orléans, France)
| |
Correlation between parameters of quality of life in patients with non-small cell lung cancer treated by chemotherapy and radiotherapy
M. Rancic, S. Rancic, M. Cekic, I. Stankovic, T. Pejcic, L. Ristic, M. Radovic (Nis, Serbia And Montenegro)
| |
Increased vascular-endothelial growth factor a (VEGF-A) expression and response to angiogenesis inhibitor erlotinib in non-small-cell lung cancer (NSCLC) – hint for a new predictive marker?
W. Brueckl, R. Wirtz, A. Schoeberl, S. Murray, S. Zirlik, E. Hahn, G. Wiest (Erlangen, Leverkusen, Germany; Athens, Greece)
| |
Surgery of new growths of a chest wall
Y. V. Birukov, V. D. Parshin, L. M. Gudovsky, G. A. Vishnevskaya (Moscow, Russian Federation)
| |
Long term survivors after radical surgery NSCLC
G. Radosavljevic Asic, D. Subotic, T. Adzic, S. Adzemovic (Belgrade, Serbia And Montenegro)
| |
Once a day (QD) thoracic radiotherapy (XRT) for patients with limited stage small-cell lung cancer (SCLC) treated concurrently with etoposide and cisplatin (EP): results of a single institution retrospective experience
S. Couraud, A. Direito, I. Martel Lafay, D. Arpin, C. Depagne, P. Nesme, J. C. Guerin, M. Perol (Lyon, France)
| |
Anti-tumor activities by a ginsenoside Rg3 formulation prepared from Korean ginseng in mouse lung cancer model
H. W. Kim, W. S. Yang, Y. M. Sohn, H. S. Shin, S. H. Son, K. C. Shin, K. H. Lee (Yeonju, Gyeongsangbuk-do, Daegu, Republic Of Korea)
| |
The role of bisphosphonates in lung cancer patients with bone metastases
K. Zarogoulidis, E. Boutsikou, T. Kontakiotis, K. Eleftheriou, E. Eleftheriadou, G. Balasoulis, T. Tsouda (Thessaloniki, Greece)
| |